Edition:
United States

Magforce AG (MF6G.F)

MF6G.F on Frankfurt Stock Exchange

4.18EUR
26 Sep 2016
Change (% chg)

€0.03 (+0.63%)
Prev Close
€4.15
Open
€4.35
Day's High
€4.35
Day's Low
€4.18
Volume
1,767
Avg. Vol
9,000
52-wk High
€5.90
52-wk Low
€3.95

MF6G.F

Chart for MF6G.F

About

Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally;... (more)

Overall

Beta: 0.16
Market Cap(Mil.): €109.56
Shares Outstanding(Mil.): 25.62
Dividend: --
Yield (%): --

Financials

  MF6G.F Industry Sector
P/E (TTM): -- 42.52 36.60
EPS (TTM): -0.06 -- --
ROI: -6.20 -0.26 13.91
ROE: -6.54 -3.05 14.82

BRIEF-MagForce FY net loss widens to EUR 1.5 mln

* Said on Thursday FY net loss was at 1.5 million euros ($1.66 million), so that is 0.5 million euros above the previous year (2014: 1.0 million euros)

Jul 01 2016

BRIEF-Magforce: initiation of Commercial NanoTherm treatments for brain cancer

* Announces initiation of Commercial NanoTherm treatments for brain cancer at Vivantes Friedrichshain in collaboration with Charité - Universitaetsmedizin Berlin Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Apr 26 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : GlobalData
$300.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.